                         SEQUENCE LISTING

<110>  ULB
 
<120>  Treatment by the administration of anti-HER2 targeted active 
       compounds to patients with early breast cancer and Her2-negative 
       primary tumor

<130>  ULBB 157

<160>  10    

<170>  PatentIn version 3.3

<210>  1
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CK19 Forward primer

<400>  1
gcactacagc cactactaca cga                                             23


<210>  2
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CK19 Reverse primer

<400>  2
ctcatgcgca gagcctgtt                                                  19


<210>  3
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Mammaglobin A Forward Primer 1

<400>  3
caatcaatcc acaagtgtct aa                                              22


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Mammaglobin A Forward Primer 2

<400>  4
acggatgaaa ctctgagcaa tg                                              22


<210>  5
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Mammaglobin A Reverse Primer 1

<400>  5
aacatgtata gcaggtttca ac                                              22


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Mammaglobin A Reverse Primer 2

<400>  6
cagttctgtg agccaaaggt                                                 20


<210>  7
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Her2 Forward Primer 1

<400>  7
tcctcctcgc cctcttgc                                                   18


<210>  8
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Her2 Forward Primer 2

<400>  8
agccgcgagc acccaagt                                                   18


<210>  9
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Her2 Reverse Primer 1

<400>  9
gcgggtctcc attgtcta                                                   18


<210>  10
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Her2 Reverse Primer 2

<400>  10
ttggtgggca ggtaggtgag t                                               21


